Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vistagen Therapeutics Inc (NQ: VTGN )

4.660 -0.210 (-4.31%)
Streaming Delayed Price Updated: 2:51 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vistagen Therapeutics Inc

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases Q2 2022 Financial Numbers, Corporate Highlights
Via Investor Brand Network
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Host Call, Release Q2 2022 Financial Report and Development Update
Via Investor Brand Network
Why VistaGen Therapeutics' Stock Is Trading Higher Today
VistaGen Therapeutics (NASDAQ:VTGN) shares are tradin... 
Via Benzinga
VistaGen Therapeutics Inc. Expands Clinical Development of PH94B with Initiation of Phase 2A AjDA Trial
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression, and... 
Via Benzinga
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Expands Clinical Development of PH94B with Initiation of Phase 2A AjDA Trial
Via Investor Brand Network
Exposures COVID-19
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases Data on New Preclinical Mechanism of Action Regarding Potential Anti-Anxiety Activity
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers MorphoSys (NASDAQ:MOR) stock move... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Cellect Biotechnology (NASDAQ:APOP 
Via Benzinga
Recap: VistaGen Therapeutics Q1 Earnings
Shares of VistaGen Therapeutics (NASDAQ:VTGN) fell 1.5% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 42.86% over the... 
Via Benzinga
Looking Into VistaGen Therapeutics's Return On Capital Employed
In Q4, VistaGen Therapeutics (NASDAQ:VTGN) posted sales of $441.90 thousand. Earnings were up 17.36%, but VistaGen Therapeutics still reported an overall loss of $6.22 million.... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Dare Bioscience (NASDAQ:DARE) sto... 
Via Benzinga
VistaGen Therapeutics Insights: Return On Capital Employed
During Q4, VistaGen Therapeutics's (NASDAQ:VTGN) reported sales totaled $441.90 thousand. Despite a 17.36% in earnings, the company posted a loss of $6.22 million. In Q3, VistaGen... 
Via Benzinga
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 146 stocks hit new 52-week highs. Interesting Facts: The largest company by market cap to set a new 52-week high was Microsoft (NASDAQ:... 
Via Benzinga
The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) Alexion Pharmaceuticals, Inc... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share. Cuentas Inc. (NASDAQ: CUEN... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Why VistaGen Therapeutics Stock Jumped Today
Investors liked the drugmaker's corporate update. 
Via The Motley Fool
VistaGen Therapeutics: Q4 Earnings Insights
Shares of VistaGen Therapeutics (NASDAQ:VTGN) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 328.57%... 
Via Benzinga
Earnings Scheduled For June 29, 2021
Companies Reporting Before The Bell • GreenPower Motor Co (NASDAQ:GP) is likely to report earnings for its fourth quarter. • Tsakos Energy Navigation (NYSE:TNP)... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Tenax Therapeutics (NASDAQ:TENX) ... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Zosano Pharma (NASDAQ:ZSAN) stock... 
Via Benzinga
VistaGen Kick Starts Late-Stage Social Anxiety Disorder Study with PH94B
VistaGen Therapeutics Inc (NASDAQ: VTGN) has initiated its PALISADE Phase 3 study to evaluate PH94B for the acute treatment of Social Anxiety Disorder (SAD). PH94B is an... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers PDS Biotechnology (NASDAQ:PDSB) shares increased by 18.99% to $6.83 during Thursday's regular session. PDS Biotechnology's stock is trading at a volume of... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday. Urban One, Inc. (NASDAQ: UONE) gained 59.1% to close at $9.56. Urban... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers Newegg Commerce Inc. (NASDAQ: NEGG) shares jumped 30% to $12.03. Precipio, Inc. (NASDAQ: PRPO) gained 22.3% to $5.05. Precipio recently announced it launched a new, four-... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2021
Upgrades According to Argus Research, the prior rating for Vontier Corp (NYSE:VNT) was changed from Hold to Buy. In the first quarter, Vontier earned $0.63. At the moment... 
Via Benzinga
Thinking About Buying Stock In Entera Bio, Allogene Or Vistagen?
Entera Bio Ltd (NASDAQ: ENTX) shares are trading higher by 3.3% at $3.10 Thursday morning after the company reported first-quarter sales results that showed year-over-... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers VistaGen Therapeutics (NASDAQ:VTGN) shares moved upwards by 14.34% to $2.63 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
Gainers PDS Biotechnology Corporation (NASDAQ: PDSB) rose 18% to $6.77 in pre-market trading as traders circulated abstract from American Society Of Clinical Oncology website.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers VistaGen Therapeutics (NASDAQ:VTGN 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.